Literature DB >> 19309306

Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

Nancy Crum-Cianflone1, Lynn Eberly, Yafeng Zhang, Anuradha Ganesan, Amy Weintrob, Vincent Marconi, R Vincent Barthel, Susan Fraser, Brian K Agan, Scott Wegner.   

Abstract

BACKGROUND: Whether human immunodeficiency virus (HIV) seroconverters have been presenting with progressively lower CD4 cell counts over the course of the HIV epidemic is controversial. Additional data on whether HIV might have become more virulent on a population level (measured by post-seroconversion CD4 cell counts) may provide important insights regarding HIV pathogenesis.
METHODS: To determine whether post-seroconversion CD4 cell counts have changed over time, we evaluated 2174 HIV seroconverters as part of a large cohort study during the period 1985-2007. Participants were documented antiretroviral-naive HIV seroconverters who had a CD4 cell count measured within 6 months after receiving a diagnosis of HIV infection. Multiple linear regression models were used to assess trends in initial CD4 cell counts.
RESULTS: The mean initial CD4 cell count decreased during the study period from 632 cells/mm(3) in 1985-1990 to 553 cells/mm(3) in 1991-1995, 493 cells/mm(3) in 1996-2001, and 514 cells/mm(3) in 2002-2007. During those periods, the percentages of seroconverters with an initial CD4 cell count <350 cells/mm(3) were 12%, 21%, 26%, and 25%, respectively. In the multiple linear model, the mean decrease in CD4 cell count from 1985-1990 was 65 cells/mm(3) in 1991-1995 (P < .001)), 107 cells/mm(3) in 1996-2001 (P < .001), and 102 cells/mm(3) in 2002-2007 (P < .001). Similar trends occurred with regard to CD4 cell percentage and total lymphocyte count. Similar decreases in initial CD4 cell counts were observed among African American and white persons during the epidemic. DISCUSSION: A significant decrease in initial CD4 cell counts among HIV seroconverters in the United States has occurred during the HIV epidemic. These data provide an important clinical correlate to suggestions that HIV may have adapted to the host, resulting in a more virulent infection.

Entities:  

Mesh:

Year:  2009        PMID: 19309306      PMCID: PMC2746018          DOI: 10.1086/597777

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.

Authors:  P Vanhems; J Lambert; M Guerra; B Hirschel; R Allard
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

3.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

4.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

5.  CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group.

Authors:  E D Gorham; F C Garland; D L Mayers; R R Goforth; S K Brodine; P J Wiess; M S McNally
Journal:  Arch Intern Med       Date:  1993-04-12

6.  Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

7.  Initial low CD4 lymphocyte counts in recent human immunodeficiency virus infection and lack of association with identified coinfections.

Authors:  P J Weiss; S K Brodine; R R Goforth; C A Kennedy; M R Wallace; P E Olson; F C Garland; F W Hall; S I Ito; E C Oldfield
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

8.  Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.

Authors:  Annika C Karlsson; Steven G Deeks; Jason D Barbour; Brandon D Heiken; Sophie R Younger; Rebecca Hoh; Meghan Lane; Matti Sällberg; Gabriel M Ortiz; James F Demarest; Teri Liegler; Robert M Grant; Jeffrey N Martin; Douglas F Nixon
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort.

Authors:  Stephanie K Brodine; Monica J Starkey; Richard A Shaffer; Stanley I Ito; Sybil A Tasker; Anthony J Barile; Cindy L Tamminga; Kevin T Stephan; Naomi E Aronson; Susan L Fraser; Mark R Wallace; Scott A Wegner; John R Mascola; Francine E McCutchan
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

10.  T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study.

Authors:  J V Giorgi; R Detels
Journal:  Clin Immunol Immunopathol       Date:  1989-07
View more
  18 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Authors:  Christine M Hogan; Victor Degruttola; Xin Sun; Susan A Fiscus; Carlos Del Rio; C Bradley Hare; Martin Markowitz; Elizabeth Connick; Bernard Macatangay; Karen T Tashima; Beatrice Kallungal; Rob Camp; Tia Morton; Eric S Daar; Susan Little
Journal:  J Infect Dis       Date:  2011-12-15       Impact factor: 5.226

3.  Are HIV-positive persons progressing faster after diagnosis over the epidemic?

Authors:  Nancy F Crum-Cianflone; Qian Ren; Lynn E Eberly; Anuradha Ganesan; Amy Weintrob; Vincent Marconi; Robert V Barthel; Brian K Agan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

4.  Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Authors:  Joshua T Herbeck; Viktor Müller; Brandon S Maust; Bruno Ledergerber; Carlo Torti; Simona Di Giambenedetto; Luuk Gras; Huldrych F Günthard; Lisa P Jacobson; James I Mullins; Geoffrey S Gottlieb
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

5.  Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Authors:  Shigeru Nomura; Noriaki Hosoya; Zabrina L Brumme; Mark A Brockman; Tadashi Kikuchi; Michiko Koga; Hitomi Nakamura; Tomohiko Koibuchi; Takeshi Fujii; Jonathan M Carlson; David Heckerman; Ai Kawana-Tachikawa; Aikichi Iwamoto; Toshiyuki Miura
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

6.  Dialectical theory and the study of HIV/AIDS and other epidemics.

Authors:  Samuel R Friedman; Diana Rossi
Journal:  Dialect Anthropol       Date:  2011-12-01

7.  Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

Authors:  Raghavan Sampathkumar; Elnaz Shadabi; Ma Luo
Journal:  Adv Virol       Date:  2012-05-16

8.  Change of positive selection pressure on HIV-1 envelope gene inferred by early and recent samples.

Authors:  Izumi Yoshida; Wataru Sugiura; Junko Shibata; Fengrong Ren; Ziheng Yang; Hiroshi Tanaka
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

9.  Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.

Authors:  Luuk Gras; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Joep Lange; Jan M Prins; Ben Berkhout; Frank de Wolf
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

10.  Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM?

Authors:  Luuk Gras; Ronald B Geskus; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Jan M Prins; Ben Berkhout; Frank de Wolf
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.